Eyegate Pharma Stock Price (NASDAQ:EYEG)

Add to My Stocks
$0.35 $0 (0%) EYEG stock closing price Sep 21, 2018 (Closing)
Prev Close* : $0.35
Market Cap:
$15.08M
Day Low: $0.35
52 Week Low: $0.29
Open: $0.35
Volume: -
Day High: $0.37
52 Week High: $1.38
Dividend:
0.00

Latest Stock Market News

Latest Articles

Eyegate Pharma News - From Partners

EyeGate Announces $11.25 Million Public Offering   by Globe Newswire on Apr 13, 2018

EYEG Stockcharts

View EYEG PE ratio, PS ratio stocks charts and compare with peers.
EYEG Chart
Note: Compare Eyegate Pharma stock price history with the index and industry peers.

Eyegate Pharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
4.22
PB ratio (
price to book ratio
)
1.35

Eyegate Pharma Returns

ROE
(return on equity)
-274%

Eyegate Pharma Financial Ratios

Asset Turnover
0.06
Receivables Turnover
8.55
Debt to Equity
0
Dividend Yield
0%

EYEG Industry Peers

Company Price Change (%)
Collplant Hldgs (CLGN)5.10.05 (0.97%)
Essa Pharma (EPIX)2.670.33 (11%)
Regeneron Pharma (REGN)390.283.03 (0.78%)
Clearside Biomedical (CLSD)6.230.29 (4.45%)
Adverum (ADVM)5.90.15 (2.61%)
Alimera Sciences (ALIM)1.040.04 (3.7%)
Rocket Pharmact (RCKT)23.360.44 (1.85%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
SIGA Technologies (SIGA)7.230.48 (7.11%)
AcelRx Pharma (ACRX)3.950.25 (6.76%)
ChemoCentryx (CCXI)12.910.54 (4.37%)
Infinity Pharma (INFI)2.40.09 (3.9%)
Redhill Biopharma (RDHL)8.040.14 (1.77%)
Adamis Pharma (ADMP)3.10.05 (1.64%)
BioSpecifics Technologies (BSTC)58.520.78 (1.35%)
Top gainers from Medical-Drugs industry
* As of Sep 21, 2018
CompanyPriceChange (%)
Lannett Co (LCI)50.5 (9.09%)
Neptune Tech. & Bio. (NEPT)4.340.38 (8.05%)
Tetraphase Pharmaceuticals (TTPH)2.920.24 (7.59%)
CORREVIO PHARMA (CORV)4.020.27 (6.29%)
Arrowhead Pharma (ARWR)17.771.11 (5.88%)
Galectin Therapeutics (GALT)6.530.4 (5.77%)
Esperion Therapeutics (ESPR)43.162.59 (5.66%)
Top losers from Medical-Drugs industry
* As of Sep 21, 2018

Eyegate Pharmaceuticals Inc Stock News - Partner Headlines

Eyegate Pharma Financial Statements

income statement20172016201520142013
Net Sales or Revenues-----
Net Income-13.21M-13.34M-8.39M-1.77M-3.87M
Total Operating Expense14.96M14.01M6.67M1.93M3.09M
View Eyegate Pharma income statement
balance sheet20172016201520142013
Total Assets14.3M9.73M9.5M1.4M-
Total Liabilities16.23M10.06M3.42M5.02M2.57M
Shareholders Equity-1.92M-0.32M6.08M-3.61M-1.87M
View Eyegate Pharma balance sheet
cash flow statement20172016201520142013
Net Increase (Decrease) in Assets Liabilities7.11M4.41M1.01M1.48M-
Net Cash from (used by) Operating Activities-6.46M-8.41M-4.45M-0.95M-2.95M
Increase (Decrease) in Prop Plant And Equipment-0.03M-0.01M---
View Eyegate Pharma cash flow statement

Eyegate Pharma Stock Message Board

An investor needs to spend $0.35 to buy EYEG stock, as the closing Eyegate Pharma stock price is $0.35. Looking at Eyegate Pharma market capitalization, which currently stands at $15.08M, we can say that EYEG stock is a Nano Cap stock. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Eyegate Pharma stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Eyegate Pharma is worth a lot, it will most likely be reflected in an inflated Eyegate Pharma stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 297,004 shares were traded with a closing stock price of $0.35 as of Sep 21, 2018, as can be seen from Eyegate Pharma stock quote. One can view Eyegate Pharma stock chart to follow the stock price trend. Eyegate Pharma paid 0.00 stock dividends to its shareholders during last quarter. To check the historical stock price movement, all time high, and all time low of EYEG, view Eyegate Pharma stock price history.